Histone deacetylase inhibitors modulate KATP subunit transcription in HL-1 cardiomyocytes through effects on cholesterol homeostasis-Reference-Cited by-同舟云学术

Histone deacetylase inhibitors modulate KATP subunit transcription in HL-1 cardiomyocytes through effects on cholesterol homeostasis

Published:2015-08-13 Issue: Volume:6 Page:
ISSN:1663-9812
Container-title:Frontiers in Pharmacology
language:
Short-container-title:Front. Pharmacol.

Author:

Fatima Naheed,Cohen Devin C.,Sukumar Gauthaman,Sissung Tristan M.,Schooley James F.,Haigney Mark C.,Claycomb William C.,Cox Rachel T.,Dalgard Clifton L.,Bates Susan E.,Flagg Thomas P.

Publisher

Frontiers Media SA

Subject

Pharmacology (medical),Pharmacology

Reference60 articles.

1. Cloning of the promoters for the beta-cell ATP-sensitive K-channel subunits Kir6.2 and SUR1;Ashfield;Diabetes,1998

2. Histone deacetylase inhibition in the treatment of heart disease;Berry;Expert Opin. Drug Saf.,2008

3. The cardiac sarcolemmal ATP-sensitive potassium channel as a novel target for anti-arrhythmic therapy;Billman;Pharmacol. Ther.,2008

4. Fluorescence studies of the binding of the polyene antibiotics filipin 3, amphotericin B, nystatin, and lagosin to cholesterol;Bittman;Proc. Natl. Acad. Sci. U.S.A.,1972

5. Histone deacetylase (HDAC) inhibitors attenuate cardiac hypertrophy by suppressing autophagy;Cao;Proc. Natl. Acad. Sci. U.S.A.,2011

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel cholesterol‐dependent regulation of cardiac K ATP subunit expression revealed using histone deacetylase inhibitors;Physiological Reports;2020-12-23

2. Dimethylation of Histone 3 Lysine 9 is sensitive to the epileptic activity, and affects the transcriptional regulation of the potassium channel Kcnj10 gene in epileptic rats;Molecular Medicine Reports;2017-11-03

3. Beyond Anthracyclines: Preemptive Management of Cardiovascular Toxicity in the Era of Targeted Agents for Hematologic Malignancies;Current Hematologic Malignancy Reports;2017-02-23

4. Pharmacogenomics and histone deacetylase inhibitors;Pharmacogenomics;2016-11